The Vitality Study

Currently Recruiting

20 Nov to 23 Nov 2025

$5,700

This study is investigating a potential treatment for people living with chronic kidney disease. This is a healthy volunteer participant study.

Chronic kidney disease (CKD) is a long-term condition where the kidneys gradually lose their ability to filter waste and excess fluids from the blood. This can lead to a buildup of toxins in the body, causing health issues such as fatigue, swelling, and high blood pressure. CKD often develops slowly over time, sometimes without noticeable symptoms in the early stages, and is commonly linked to conditions like diabetes and hypertension. While it cannot always be cured, early detection and management can help slow its progression, improve quality of life, and reduce the risk of serious complications. 

Join our clinical trial

This is a first-in-human (FIH) study, meaning it is the first time the potential treatment is being tested in people. The study has been carefully designed with strict safety protocols and has been approved by an independent ethics committee. 

Before joining, you’ll receive detailed information about the study, meet with a doctor, and have the chance to ask any questions. 

Why participate?

  • Contribute to Research that supports communities across the globe. 
  • Help Make Treatments More Inclusive and Effective 
  • Be the Reason Better Treatments Move Forward 

Trial details

Study medication

Administered via IV infusion (a small cannula placed into the vein to
deliver the medication) or a subcutaneous injection (a small injection into the fatty
tissue).

Ethics approval

An independent ethics committee has approved this clinical trial.

Additional eligibility

  • Non-smokers, or smoking no more than 5 cigarettes per week. No tobacco or nicotine use during the study. 
  • Prescription medications must be complete 14 days prior to admission (as discussed with our medical team). 

Are you a match?

Age

18 - 60 years old

Remuneration

$5,700 *with screening reimbursement. Please see T&Cs.

Gender

Male or Female

BMI

BMI 19 - 32 kg/m2

Commitment

3 nights, 8 clinic visits

Medical condition

Not taking any medications

Register Your Interest

This form takes around 3–5 minutes to complete. Your information will remain confidential and is used only to assess your eligibility for current or future research studies.
Step 1 of 3
Contact Information




The phone number you have entered does not appear to be a valid active Australian phone number. Please check your details and enter a valid Australian phone number starting with +61

Nucleus Network does not currently conduct clinical trials in your state. If you would like to receive study information should this situation change, please complete and submit this form.
Personal Information

This includes registering your interest with the Centre for Clinical Studies, Q-Pharm or Nucleus Network

Please call us on 1800 243 733 or schedule a call.


What is your date of birth?
Day Month Year

You need to be at least 18 years old to participate in clinical trials.


cm

kg





















Step 2 of 3
Medical History

We regularly have studies that allow participants who are (social) smokers.

We define an allergy as severe if symptoms include mouth/throat/face swelling, shortness of breath or a whole-body rash, or if it required hospitalisation

We regularly have studies that allow for/require participants with asthma.



We regularly have studies that allow for/require participants with medical conditions.

Medications & Contraception Requirements

We regularly have studies that allow participants with depression that is well-managed on a stable dose of medication.

If the only prescription medication you currently use is hormonal contraception and/or Ventolin, please select No above. We regularly have studies that allow for participants who take a stable dose of prescription medication.


  • Abstinence from sex with anyone of the opposite sex for at least 2 months
  • Using a condom + your female sexual partner(s) using a separate form of birth control
  • You or your sexual partner(s) had a vasectomy/hysterectomy
  • Your sexual partner(s) are post-menopausal


Only you taking birth control or your partner(s) using a condom is not an acceptable option, but using both together is. The morning after pill is not an acceptable form of birth control.

  • Abstinence, by choice, from sex with anyone of the opposite sex for the last 2 months + remaining abstinent for at least 2 months after study participation
  • You using birth control + your male sexual partner(s) using a condom
  • You or your sexual partner(s) had a hysterectomy/vasectomy
  • You are post-menopausal



Step 3 of 3
Study Preferences

While longer studies generally have a higher reimbursement, there are also studies with multiple short stays that have high reimbursements.
Referral Information



Consent to Information Use and Future Contact